Biologics
Cell Therapies and Teijin Forge Strategic MoU to Build Asia-Pacific Cell and Gene Therapy Infrastructure
Cell Therapies Pty Ltd. (“Cell Therapies”) and Teijin Limited announced that they have signed a Memorandum of Unders...
October 02, 2025 | News
Made Scientific and Syenex Forge Partnership to Transform T Cell Therapy Manufacturing
Made Scientific, a leading cell therapy contract development and manufacturing organization (CDMO) and Syenex, a synthetic biology company specializing in ...
October 01, 2025 | News
Japan Grants Orphan Drug Designation to JR-446 for Sanfilippo Syndrome Type B
MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Co., Ltd. announced that the Ministry of Health, Labour and Welfare of Japa...
October 01, 2025 | News
PromoCell Enters GMP Market with Custom Cell Culture Media Services for Clinical Applications
PromoCell GmbH, a leading global manufacturer of primary human cells and specialized cell culture media for biomedical research, announces its entry into t...
October 01, 2025 | News
Full-Life Technologies Secures US$77 Million in Series C and Debt Financing to Advance Global Radiopharmaceutical Pipeline
Series C led by Junson Capital along with new investor syndicate and existing shareholders Funding will further advance Full-Life's global radiopharmace...
September 30, 2025 | News
WuXi XDC Co-Hosts 2025 BPD Singapore Summit Showcasing Innovation in Bioconjugates and Global Biopharma Collaboration
The 2025 BPD (Biopharmaceutical Bioprocess Development) Singapore Summit, which co-hosted by WuXi XDC (Stock Code: 2268.HK), was successfully conclude...
September 30, 2025 | News
Health Hope Pharma and Hanmi Grant Gilead Global Rights to Encequidar in Virology
Health Hope Pharma Limited announced that it has entered into a global licensing and collaboration agreement with Gilead Sciences, Inc. ("Gilead") for ence...
September 30, 2025 | News
Takara Bio Europe launches Cellartis® MSC EV Wonder™ to boost scalable, high-quality EV production
Takara Bio Europe announces the launch of Cellartis® MSC EV Wonder™, a defined, xeno-free medium engineered for the scalable production of extrac...
September 30, 2025 | News
WuXi Biologics Launches TrueSite TI™, a Next-Generation Targeted Integration Cell Line Platform Redefining Biologics Development
TrueSite TI™, the fourth generation of WuXia™ cell line platform, leverages targeted integration technique to streamline clone scre...
September 29, 2025 | News
Catalent Opens New Global Headquarters in Tampa to Shape the Future of Biopharma Innovation
Relocation reflects a strategic expansion in Florida alongside long-standing manufacturing facility in nearby St. Petersburg New ...
September 29, 2025 | News
Hengrui Pharma Grants Glenmark Exclusive Global Licence for HER2-Targeted ADC Trastuzumab Rezetecan
Hengrui Pharma, a leading innovative global pharmaceutical company focused on scientific and technological innovation, announced that it has entered ...
September 25, 2025 | News
Lonza and RION Partner to Scale Manufacturing of Exosome-Based Therapy PEP™
Lonza to support cGMP manufacturing of RION’s Purified Exosome Product™ (PEP™), a platelet-derived exosome-based drug candidate ...
September 24, 2025 | News
Akeso Doses First Patient in Phase II Study of Novel TIGIT/TGF-β Bifunctional Antibody for Pancreatic Cancer
Akeso Inc. has announced that the first patient has been dosed in its registrational Phase II study (AK130-202), evaluating AK130, a fully independent...
September 23, 2025 | News
SOPHiA GENETICS Expands Collaboration with AstraZeneca to Advance AI-Powered Genomic Testing in Breast and Prostate Cancer
SOPHiA GENETICS an AI technology company transforming precision medicine announced an expansion of its collaboration with AstraZeneca (LSE/STO/Nasdaq:...
September 23, 2025 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
